Clinical Trial

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

Study acronym: PASC24
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2025 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The prospective, longitudinal, open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the disease has affected their physical, psychological and cognitive function, their ability to be active, return to work, their health-related quality of life in correlation with potential diagnostic and prognostic markers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-06.
Status change: Recruiting → Active, Not Recruiting 2025-02-07
Trial Details
NCT Number NCT06298006
Lead Sponsor Region Örebro County
Collaborators: Örebro University, Sweden, Karolinska Institutet, Karolinska University Hospital, Sahlgrenska University Hospital
Conditions COVID-19
Enrollment 57 participants
Start Date 2022-02-22
Primary Completion 2026-05-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-11